P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY.

التفاصيل البيبلوغرافية
العنوان:	P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY.
المؤلفون:	Garcia-Manero, G., Bart, S., McCloskey, J. K., Fenaux, P., Selleslag, D., Reda, G., Valcárcel, D., Santini, V., Mayer, J., Xicoy, B., Yamaguchi, H., Lübbert, M., Miyazaki, Y., Keer, H., Hao, Y., Azab, M., Döhner, H.
المصدر:	HemaSphere ; volume 6, page 663-664 ; ISSN 2572-9241
بيانات النشر:	Wiley
سنة النشر:	2022
المجموعة:	Wiley Online Library (Open Access Articles via Crossref)
نوع الوثيقة:	article in journal/newspaper
اللغة:	English
DOI:	10.1097/01.hs9.0000845956.26644.d0
DOI:	10.1097/01.HS9.0000845956.26644.d0
الاتاحة:	http://dx.doi.org/10.1097/01.hs9.0000845956.26644.d0 https://journals.lww.com/10.1097/01.HS9.0000845956.26644.d0
Rights:	http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام:	edsbas.D002B636
قاعدة البيانات:	BASE

الوصف
DOI:	10.1097/01.hs9.0000845956.26644.d0